SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months–4 Years — New Vaccine Surveillance Network, United States, July 2022–Septembe
by from Morbidity and Mortality Weekly Report (MMWR) on (#6GSJ8)
This report describes the effectiveness of COVID-19 mRNA vaccines among infants and children aged 6 months-4 years.